Schuh, M. P., Bennett, M. R., Lane, A., Jodele, S., Laskin, B. L., & Devarajan, P. (2019). Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy. Pediatric Nephrology, 34(5), 865. https://doi.org/10.1007/s00467-018-4178-x
Chicago Style (17th ed.) CitationSchuh, Meredith P., Michael R. Bennett, Adam Lane, Sonata Jodele, Benjamin L. Laskin, and Prasad Devarajan. "Haptoglobin Degradation Product as a Novel Serum Biomarker for Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy." Pediatric Nephrology 34, no. 5 (2019): 865. https://doi.org/10.1007/s00467-018-4178-x.
MLA (9th ed.) CitationSchuh, Meredith P., et al. "Haptoglobin Degradation Product as a Novel Serum Biomarker for Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy." Pediatric Nephrology, vol. 34, no. 5, 2019, p. 865, https://doi.org/10.1007/s00467-018-4178-x.